[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366972-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366972-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-transcriptomic-analysis-of-cancer-stromal-interactome-in-lung-cancer-xenograft-models","A Transcriptomic Analysis of Cancer-Stromal Interactome in Lung Cancer Xenograft Models","","Cancer-stromal interactions are central to the biology of lung adenocarcinoma. The study aimed to comprehensively map the lung cancer interactome and determine key ligand–receptor pairs linked to aggressiveness. Transcriptomic profiles were generated from xenografts using 11 lung cancer cell lines covering major driver mutations, producing quantitative stroma-to-cancer and cancer-to-stroma datasets. From 1150 identified interactions, 117 were shortlisted by ligand–stromal intensity scores and further refined to 21 prognostic ligand–receptor pairs. Tumor necrosis factor superfamily member 12/tumor necrosis factor receptor superfamily member 12A was prioritized, with immunohistochemistry confirming stromal and cancer-specific expression and clinical correlations with tumor size.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-transcriptomic-analysis-of-cancer-stromal-interactome-in-lung-cancer-xenograft-models/366972/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-transcriptomic-analysis-of-cancer-stromal-interactome-in-lung-cancer-xenograft-models/366972.png","ImageObject",300,407,{"name":42,"@type":43},"pixelkiddo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main objective of the transcriptomic analysis?","Question",{"text":63,"@type":64},"To comprehensively analyze the lung cancer cancer-stromal interactome and identify key ligand–receptor pairs associated with aggressiveness in lung adenocarcinoma.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were transcriptome datasets generated in the study?",{"text":68,"@type":64},"Transcriptome data were obtained from xenografts of 11 lung cancer cell lines representing major driver mutations, and quantitative datasets were built in both stroma-to-cancer and cancer-to-stroma directions.",{"name":70,"@type":61,"acceptedAnswer":71},"Which ligand–receptor signaling axis was highlighted as a possible contributor to aggressiveness?",{"text":72,"@type":64},"Tumor necrosis factor superfamily member 12 and tumor necrosis factor receptor superfamily member 12A were selected as possible factors, supported by immunohistochemical expression patterns.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366972,1791192635,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090883892,"https://ap-avatar.wpscdn.com/avatar/e00115db34f3e0f11b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1790152879550218658","Cancer Science  \nORIGINAL ARTICLE  OPEN ACCESS   \nA Transcriptomic Analysis of Cancer-Stromal Interactomein Lung Cancer Xenograft Models  \nYuriko Takayama-Isagawa1  | Daisuke Komura2  | Takayuki Isagawa3 | Yusuke Amano1 | Atsushi Kihara1,4 |  \nTamaki Miura1 | Taichiro Yoshimoto1,5 | Hiroyoshi Tsubochi6 | Kazutaka Fujita7 | Koichi Hagiwara7 | Makoto Maemondo7 | Tetsuo Ushiku8 | Shumpei Ishikawa2,9 | Noriyoshi Fukushima10 | Kentaro Inamura1,11  | Daisuke Matsubara1,12 | Toshiro Niki1  \n1Division of Tumor Pathology, Department of Pathology, Jichi Medical University, Shimotsuke, Japan | 2Department of Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan | 3Data Science Center, Jichi Medical University, Shimotsuke, Japan | 4Department of Molecular Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Japan | 5Division of Diagnostic Pathology, Showa General Hospital, Japan | 6Division of General Thoracic Surgery, Department of Surgery, School of Medicine, Jichi Medical University, Shimotsuke, Japan | 7Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Shimotsuke, Japan | 8Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan | 9Division of Pathology, Exploratory Oncology Research & Clinical Trial Center, National  \nCancer Center, Chiba, Japan | 10Division of Comprehensive Pathology, Department of Pathology, Jichi Medical University, Shimotsuke, Japan | 11Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan | 12Department of Pathology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan  \nCorrespondence: Toshiro Niki ([tniki@jichi.ac.jp](tniki@jichi.ac.jp))  \nReceived: 29 November 2024 | Revised: 31 October 2025 | Accepted: 11 November 2025  \nKeywords: cell to cell interaction | immunohistochemistry | lung adenocarcinoma | tumor microenvironment | xenograft  \nABSTRACT  \nCancer-stromal interactions play important roles in the biology of various cancers, including lung adenocarcinoma. We aimed to comprehensively analyze the lung cancer interactome and identify the key ligand–receptor pairs involved in the aggressiveness of lung adenocarcinoma. Transcriptome data were obtained from xenografts of 11 lung cancer cell lines that represented the major driver mutations in lung adenocarcinomas. A quantitative dataset was constructed in both stroma-to-cancer and cancerto-stroma directions using the cancer-stromal interactome analysis method. The prognostic value of each factor was evaluated using multiple datasets. Analysis of 24,250 stroma-derived mouse transcripts and 26,289 human cancer-derived transcripts identified 1150 cancer-stromal interactions, from which we selected 117 interactions based on the intensity score of ligand–stromal transcript levels. Further prognostic analysis using public databases led us to identify 21 ligand–receptor pairs, including wellknown as well as less well-characterized ligand–receptor pairs. Therefore, we selected tumor necrosis factor superfamily member 12/tumor necrosis factor receptor superfamily member 12A as possible factors contributing to the aggressiveness of lung adenocarcinoma via cancer-stromal interactions; immunohistochemical analysis confirmed that these factors were expressed mainly in the stroma and cancer cells, respectively, in both xenografts and primary lung adenocarcinoma. In human clinical specimens, high tumor necrosis factor receptor superfamily member 12A expression significantly correlated with tumor size,  \n\n| Abbreviations: CASTIN, CAncer-STromal INteractome analysis; CO2, Carbon Dioxide; CS, Cancer Cells to Stromal Cells; EGFR, Epidermal Growth Factor Receptor; FLT1, Fms-Like Tyrosine kinase-1; GAIIx, Genome Analyzer IIx (Illumina); HGF, Hepatocyte Growth Factor; JMP Pro, JMP Professional (software); KDR, Kinase Insert Domain Receptor; Mcl-1, Myeloid Cell Leukemia 1; MET, Mesenchymal-Epithelial Transitio","cbCainfBcQX8iDN7","https://ap.wps.com/l/cbCainfBcQX8iDN7","pdf",960599,11,"English","# Abstract\n## Introduction","[{\"question\":\"What was the main objective of the transcriptomic analysis?\",\"answer\":\"To comprehensively analyze the lung cancer cancer-stromal interactome and identify key ligand–receptor pairs associated with aggressiveness in lung adenocarcinoma.\"},{\"question\":\"How were transcriptome datasets generated in the study?\",\"answer\":\"Transcriptome data were obtained from xenografts of 11 lung cancer cell lines representing major driver mutations, and quantitative datasets were built in both stroma-to-cancer and cancer-to-stroma directions.\"},{\"question\":\"Which ligand–receptor signaling axis was highlighted as a possible contributor to aggressiveness?\",\"answer\":\"Tumor necrosis factor superfamily member 12 and tumor necrosis factor receptor superfamily member 12A were selected as possible factors, supported by immunohistochemical expression patterns.\"}]","A Transcriptomic Analysis of Cancer-Stromal Interactome in Lung Cancer Xenograft Models | PDF",1790168509,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7432c8322d68ba8de0ac59beb0c266ed.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d006d456f029444edf7100e16d30752.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3693b236029cd0fd3b333fd63447035.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb15763b3ad4862bb46ae1dc3afe99a4.webp",980,1287]